This is not the most recent version of the article. View current version (24 FEB 2015)

Intervention Protocol

You have free access to this content

Medical interventions for acanthamoeba keratitis

  1. Majed Alkharashi1,*,
  2. Kristina Lindsley2,
  3. Shameema Sikder3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 21 OCT 2013

DOI: 10.1002/14651858.CD010792

How to Cite

Alkharashi M, Lindsley K, Sikder S. Medical interventions for acanthamoeba keratitis (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010792. DOI: 10.1002/14651858.CD010792.

Author Information

  1. 1

    Johns Hopkins University School of Medicine, Department of Ophthalmology, Baltimore, MD, USA

  2. 2

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland, USA

  3. 3

    Johns Hopkins University School of Medicine, Wilmer Ophthalmological Institute, Baltimore, Maryland, USA

*Majed Alkharashi, Department of Ophthalmology, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Maumenee #317, Baltimore, MD, 21287, USA.

Publication History

  1. Publication Status: New
  2. Published Online: 21 OCT 2013


This is not the most recent version of the article. View current version (24 FEB 2015)


Additional references

Acharya 2007
  • Acharya NR, Lietman TM, Margolis TP. Parasites on the rise: a new epidemic of Acanthamoeba keratitis. American Journal of Ophthalmology 2007; Vol. 144, issue 2:292-3.
Alizadeh 2001
  • Alizadeh H, Apte S, El-Agha MS, Li L, Hurt M, Howard K, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea 2001;20(6):622–7.
Alizadeh 2005
  • Alizadeh H, Neelam S, Hurt M, Niederkorn JY. Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis. Infection and Immunity 2005;73(2):1061-8.
Awwad 2007
  • Awwad ST, Petroll WM, McCulley JP, Cavanagh HD. Updates in Acanthamoeba keratitis. Eye and Contact Lens 2007;33(1):1-8.
Biddick 1984
  • Biddick CJ, Rogers LH, Brown TJ. Viability of pathogenic and nonpathogenic free-living amoebae in long-term storage at a range of temperatures. Applied and Environmental Microbiology 1984;48(4):859-60.
Borin 2013
  • Borin S, Feldman I, Ken-Dror S, Briscoe D. Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli. Journal of Ophthalmic Inflammation and Infection 2013;3(1):40.
Brandt 1989
  • Brandt FH, Ware DA, Visvesvara GS. Viability of Acanthamoeba cysts in ophthalmic solutions. Applied and Environmental Microbiology 1989;55(5):1144-6.
Butler 2005
Claerhout 2004
  • Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2004;242(8):648-53.
Dart 2008
  • Dart JK, Radford CF, Minassian D, Verma S, Stapleton F. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology 2008;115(10):1647-54.
Dart 2009
Garate 2006
  • Garate M, Marchant J, Cubillos I, Cao Z, Khan NA, Panjwani N. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Investigative Ophthalmology and Visual Science 2006;47(3):1056-62.
Glanville 2006
  • Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
Gray 1995
Hammersmith 2006
Hay 1994
Herz 2008
Higgins 2011
  • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from
Hiti 2005
  • Hiti K, Walochnik J, Faschinger C, Haller-Schober EM, Aspöck H. One- and two-step hydrogen peroxide contact lens disinfection solutions against Acanthamoeba: how effective are they?. Eye 2005;19(12):1301-5.
Ibrahim 2007
Johnston 2009
  • Johnston SP, Sriram R, Qvarnstrom Y, Roy S, Verani J, Yoder J, et al. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. Journal of Clinical Microbiology 2009;47(7):2040-5.
Kilvington 2004
  • Kilvington S, Gray T, Dart J, Morlet N, Beeching JR, Frazer DG, et al. Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. Investigative Ophthalmology and Visual Science 2004;45(1):165-9.
Kim 2010
Lehmann 1998
  • Lehmann OJ, Green SM, Morlet N, Kilvington S, Keys MF, Matheson MM, et al. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Investigative Ophthalmology and Visual Science 1998;39(7):1261-5.
Lindsay 2007
Mathers 1997
Matoba 1989
Murthy 2002
Naginton 1974
Neff 1969
  • Neff RJ, Neff RH. The biochemistry of amoebic encystment. Symposia of the Society for Experimental Biology 1969;23:51-81.
Oh 2010
  • Oh JY, Lee HJ, Khwarg SI, Wee WR. Corneal cell viability and structure after transcorneal freezing-thawing in the human cornea. Clinical Ophthalmology 2010;4:477-80.
Park 2002
  • Park JT, Jeong YE, Ahn TI. Changes in profiles of major proteins in encysting Acanthamoeba castellanii. Korean Journal of Biological Sciences 2002;6(4):341–7.
Pérez-Santonja 2003
  • Pérez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. Ophthalmology 2003;110(8):1593-600.
Radford 2002
Review Manager 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rezaei Kanavi 2012
  • Rezaei Kanavi M, Naghshgar N, Javadi MA, Sadat Hashemi M. Various confocal scan features of cysts and trophozoites in cases with Acanthamoeba keratitis. European Journal of Ophthalmology 2012;22 Suppl 7:S46-50.
Seal 1999
Seal 2003
Sharma 2000
Speer 2003
  • Speer CE, Hofmeister EM, Cohen EJ. An atypical presentation of Acanthamoeba keratitis in a noncontact lens wearer. Eye Contact Lens 2003;29(1):21-2.
Stehr-Green 1987
Stehr-Green 1989
Sun 2006
Thebpatiphat 2007
  • Thebpatiphat N, Hammersmith KM, Rocha FN, Rapuano CJ, Ayres BD, Laibson PR, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea 2007;26(6):701-6.
Tu 2008
US DHHS 1986
  • US Department of Health and Human Services, Public Health Service. Acanthamoeba keratitis associated with contact lenses-United States. Morbidity and Mortality Weekly Report 1986;35(25):405-8.
Vaddavalli 2011
Walochnik 2000
  • Walochnik J, Haller-Schober E, Kölli H, Picher O, Obwaller A, Aspöck H. Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens-wearing keratitis patients in Austria. Journal of Clinical Microbiology 2000;38(11):3932-6.
Watson 2012
  • Watson S, Dart J. Section 3: 16c. Acanthamoeba keratitis. In: Johnson GJ, Minassian DC, Weale RA, West SK editor(s). The Epidemiology of Eye Disease. 3rd Edition. Imperial College Press, 2012.
Watt 2005
  • Watt K, Swarbrick HA. Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 2005;31(5):201-8.
Winchester 1995
Wright 1985
Yoder 2012
  • Yoder JS, Verani J, Heidman N, Hoppe-Bauer J, Alfonso EC, Miller D, et al. Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiology 2012;19(4):221-5.